Diabetes and CFAP126 gene mutation; are they really linked together?
-
Kashan Arshad
, Aamir Naseem
, Syed Saddam Hussain
, Noor-ul-ain Mehak , Awais Muhammad Butt , Sommayya Aftab, Anjum Saeed
and Huma Arshad Cheema
Abstract
Objectives
We are reporting a rare case series of 2 siblings and their mother with diabetes having a CFAP126 gene mutation.
Case presentation
Two female siblings, presented with incidental hyperglycemia at the ages of 16 and 13. They had a strong family history of diabetes on the maternal side. The systemic examination was unremarkable. Sibling 1 had HbA1C of 12.3 % with insulin and C-peptide levels of 6.6 IU/L and 1.8 ng/mL, respectively. Sibling 2 had an HbA1C of 12.6 %, an insulin level of 7.3 IU/L, and a C-peptide level of 2.02 ng/mL. Anti-GAD-65 and IA2 antibodies were negative. Mother also shared similar clinical processes and exhibited comparable biochemical changes related to glucose metabolism with elevated HbA1C levels and negative autoimmune markers (anti-GAD65 and IA2 antibodies). Whole exome sequencing (WES) turned out to be negative for MODY variants but revealed a rare heterozygous mutation in the CFAP126 gene (c.310A>T p. (Lys104*) in this family including both siblings and mother. The pathogenicity prediction tool MutationTaster® classified the mutation as disease causing. Oral glibenclamide remarkably reduced insulin requirements and improved HbA1C levels.
Conclusions
This rare genetic mutation is likely associated with diabetes and possibly a novel marker for a yet to be identified type of diabetes, that is responsive to oral sulfonylureas. The influence of this gene on insulin secretion needs to be confirmed through future research.
-
Research ethics: The local Institutional Review Board deemed the study exempt from review.
-
Informed consent: Informed consent was taken from parents for publication of this data and accompanying images.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Research funding: This case report did not receive any specific grant from any funding agency in the public, commercial or non-profit sector.
References
1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014;37:S81–90. https://doi.org/10.2337/dc14-s081.Search in Google Scholar
2. Bader, E, Migliorini, A, Gegg, M, Moruzzi, N, Gerdes, J, Roscioni, SS, et al.. Identification of proliferative and mature β-cells in the islets of Langerhans. Nature 2016;535:430–4. https://doi.org/10.1038/nature18624.Search in Google Scholar PubMed
3. Kume, S. Heterogeneity of β‐cells. J Diabetes Investig 2017;8:656. https://doi.org/10.1111/jdi.12608.Search in Google Scholar PubMed PubMed Central
4. Schwarz, JM, Cooper, DN, Schuelke, M, Seelow, D. Mutationtaster2: mutation prediction for the deep-sequencing age. Nat Methods 2014;11:361–2. https://doi.org/10.1038/nmeth.2890.Search in Google Scholar PubMed
5. Salomon, D, Meda, P. Heterogeneity and contact-dependent regulation of hormone secretion by individual B cells. Exp Cell Res 1986;162:507–20. https://doi.org/10.1016/0014-4827(86)90354-x.Search in Google Scholar PubMed
6. Heimberg, H, De Vos, A, Vandercammen, A, Van Schaftingen, E, Pipeleers, D, Schuit, F. Heterogeneity in glucose sensitivity among pancreatic beta‐cells is correlated to differences in glucose phosphorylation rather than glucose transport. EMBO J 1993;12:2873–9. https://doi.org/10.1002/j.1460-2075.1993.tb05949.x.Search in Google Scholar PubMed PubMed Central
7. CFAP126 cilia and flagella associated protein 126 [homo sapiens (human)] – gene, NCBI [Internet]. National Center for Biotechnology Information. U.S. National Library of Medicine; [cited 2024 Apr 19]. Available from: https://www.ncbi.nlm.nih.gov/gene/257177Search in Google Scholar
8. Lange, A, Gegg, M, Burtscher, I, Bengel, D, Kremmer, E, Lickert, H. FltpT2AiCre: a new knock-in mouse line for conditional gene targeting in distinct mono-and multiciliated tissues. Differentiation 2012;83:S105–13. https://doi.org/10.1016/j.diff.2011.11.003.Search in Google Scholar PubMed
9. DiIorio, P, Rittenhouse, AR, Bortell, R, Jurczyk, A. Role of cilia in normal pancreas function and in diseased states. Birth Defects Res., Part C 2014;102:126–38. https://doi.org/10.1002/bdrc.21064.Search in Google Scholar PubMed
10. Fadl, SM, Kafaji, M, Abdalla, H, Dabbour, MA, Al-Shamrani, A, Abdalla, HM, et al.. Primary ciliary dyskinesia and type 1 diabetes: true association or circumstantial? Cureus 2023;15. https://doi.org/10.7759/cureus.39344.Search in Google Scholar PubMed PubMed Central
© 2024 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Review
- Refractory hypothyroidism in children: an overview
- Original Articles
- Oral glucose tolerance test curve shape in Mexican children and adolescents with and without obesity
- Reliability of self-reported pubertal development scale for girls in early adolescent: a school population-based study
- Allergic reactions to enzyme replacement therapy in children with lysosomal storage diseases and their management
- The role of Cardiotrophin-1 and echocardiography in early detection of subclinical diabetic cardiomyopathy in children and adolescents with type 1 diabetes mellitus
- Evaluation of the etiology of subclinical hypothyroidism in children
- Long-term efficacy and safety of PEGylated recombinant human growth hormone in treating Chinese children with growth hormone deficiency: a 5-year retrospective study
- Case Reports
- Effective and safe use of sirolimus in hyperinsulinemic hypoglycaemia refractory to medical and surgical therapy: a case series and review of literature
- Diabetes and CFAP126 gene mutation; are they really linked together?
- Pronounced neonatal breast enlargement beyond the first week of life and its regression correlates with serum prolactin levels – a case series
- A successful liver transplantation in a patient with neonatal-onset carbamoyl phosphate synthetase-1 deficiency
- Corrigendum
- New data supporting that early diagnosis and treatment are possible and necessary in intracellular cobalamin depletion: the case of transcobalamin II deficiency
Articles in the same Issue
- Frontmatter
- Review
- Refractory hypothyroidism in children: an overview
- Original Articles
- Oral glucose tolerance test curve shape in Mexican children and adolescents with and without obesity
- Reliability of self-reported pubertal development scale for girls in early adolescent: a school population-based study
- Allergic reactions to enzyme replacement therapy in children with lysosomal storage diseases and their management
- The role of Cardiotrophin-1 and echocardiography in early detection of subclinical diabetic cardiomyopathy in children and adolescents with type 1 diabetes mellitus
- Evaluation of the etiology of subclinical hypothyroidism in children
- Long-term efficacy and safety of PEGylated recombinant human growth hormone in treating Chinese children with growth hormone deficiency: a 5-year retrospective study
- Case Reports
- Effective and safe use of sirolimus in hyperinsulinemic hypoglycaemia refractory to medical and surgical therapy: a case series and review of literature
- Diabetes and CFAP126 gene mutation; are they really linked together?
- Pronounced neonatal breast enlargement beyond the first week of life and its regression correlates with serum prolactin levels – a case series
- A successful liver transplantation in a patient with neonatal-onset carbamoyl phosphate synthetase-1 deficiency
- Corrigendum
- New data supporting that early diagnosis and treatment are possible and necessary in intracellular cobalamin depletion: the case of transcobalamin II deficiency